1st European Stakeholder Workshop: Towards an Improved Strategy for Regulatory Support for Academia
The 1st European Stakeholder Workshop
of STARS was conducted virtually due to the ongoing Covid-19 pandemic
on 3-4 November 2020. In total, 100 participants attended the online
workshop, representing academic researcher, clinical centers, clinical
research networks, funding bodies, regulators from national competent
authorities, patient representatives, and industry representatives.
More...
Find Support in Regulatory Affairs – our Comprehensive Inventory
The purpose of this Comprehensive
Inventory (CI) is to assist European academic drug developers in finding
support on regulatory affairs. The inventory lists various support
services provided by national competent authorities, public actors and
private entities. You can browse the data collection by country,
expertise area and support scope. Plus: provider profiles can be
downloaded in PDF format.
More...
New Publication: Strengthening Regulatory Science in Academia
'Strengthening regulatory science in
academia: STARS – an EU initiative to bridge the translational gap' is
the title of a new publication currently available in a pre-print
version. It outlines what regulatory-related barriers hamper the
translational development of novel products or new treatment paradigms
initiated in academia, and proposes key steps towards improved
regulatory dialogue among academia, funding bodies and regulatory
authorities.
More...
Outlook for 2021
The STARS consortium pursues different activities in the upcoming months. A major aim is to development the Common Strategy, which one the hand will be based on the STARS activities that have been established so far, including the outcomes of the STARS surveys and the 1st Stakeholder Workshop. On the other hand, the Common Strategy will also take the upcoming activities into account, like the development of a core and a comprehensive curriculum and the STARS pilots into account.
The STARS consortium plans a second
stakeholder workshop at the end of 2021 with the aim to discuss and
adapt the Common Strategy together will the relevant stakeholders and
target groups.
|
